Azmi Nabulsi
2019
In 2019, Azmi Nabulsi earned a total compensation of $531K as Chief Operating Officer at Phathom Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $142,507 |
|---|---|
| Salary | $388,522 |
| Total | $531,029 |
Nabulsi received $388.5K in salary, accounting for 73% of the total pay in 2019.
Nabulsi also received $142.5K in non-equity incentive plan.
Rankings
In 2019, Azmi Nabulsi's compensation ranked 11,587th out of 13,971 executives tracked by ExecPay. In other words, Nabulsi earned more than 17.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,587 out of 13,971 | 17th |
Division Manufacturing | 4,694 out of 5,695 | 18th |
Major group Chemicals And Allied Products | 1,849 out of 2,194 | 16th |
Industry group Drugs | 1,593 out of 1,880 | 15th |
Industry Pharmaceutical Preparations | 1,177 out of 1,392 | 15th |
Source: SEC filing on April 8, 2020.
Nabulsi's colleagues
We found three more compensation records of executives who worked with Azmi Nabulsi at Phathom Pharmaceuticals in 2019.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020